157 related articles for article (PubMed ID: 709935)
1. Short-term effects of varying doses of 1 alpha-hydroxyvitamin D3 on blood and urine chemistry and calcium absorption of osteoporotic patients.
Lindholm TS; Sevastikoglou JA; Lindgren U
Clin Orthop Relat Res; 1978 Sep; (135):226-31. PubMed ID: 709935
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Interim report on treatment of osteoporotic patients with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Sevastikoglou JA; Lindgren U
Clin Orthop Relat Res; 1978 Sep; (135):232-40. PubMed ID: 709936
[TBL] [Abstract][Full Text] [Related]
4. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.
Gallagher JC; Riggs BL; Eisman J; Hamstra A; Arnaud SB; DeLuca HF
J Clin Invest; 1979 Sep; 64(3):729-36. PubMed ID: 468987
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
[TBL] [Abstract][Full Text] [Related]
6. Results of long-term treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Eriksson S; Lindholm TC
Ital J Orthop Traumatol; 1984 Jun; 10(2):187-201. PubMed ID: 6432736
[TBL] [Abstract][Full Text] [Related]
7. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.
Bikle DD
Rheum Dis Clin North Am; 1994 Aug; 20(3):759-75. PubMed ID: 7984788
[TBL] [Abstract][Full Text] [Related]
8. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
Gallagher JC; Riggs BL; DeLuca HF
J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
[TBL] [Abstract][Full Text] [Related]
9. [Efficiency of calcium and vitamin D3 in the treatment of steroid osteoporosis in patients with hormone dependent bronchial asthma].
Ememl'ianov AV; Shevelev SE; Murzin BA; Amosov VI
Ter Arkh; 1999; 71(11):68-9. PubMed ID: 10626343
[TBL] [Abstract][Full Text] [Related]
10. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose.
Klein RG; Arnaud SB; Gallagher JC; Deluca HF; Riggs BL
J Clin Invest; 1977 Jul; 60(1):253-9. PubMed ID: 874087
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral and calcium metabolism before, during and after treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Eriksson S
Scand J Rheumatol; 1982; 11(1):55-7. PubMed ID: 7063813
[TBL] [Abstract][Full Text] [Related]
12. [Effect of cortisone on calcium metabolism. Attempt at correction by 5,6 trans 25-hydroxycholecalciferol, 25-hydroxycholecalciferol and vitamin D2].
Miravet L; Gueris J; Rousselet F; Ryckewaert A
Nouv Presse Med; 1977 May; 6(21):1847-51. PubMed ID: 301629
[TBL] [Abstract][Full Text] [Related]
13. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
[TBL] [Abstract][Full Text] [Related]
14. Short-term effects of 1-alpha-hydroxy-vitamin D3 in patients on corticosteroid treatment and in patients with senile osteoporosis.
Lindgren U; Lindholm S; Sarby B
Acta Med Scand; 1978; 204(1-2):89-92. PubMed ID: 685736
[TBL] [Abstract][Full Text] [Related]
15. [The efficacy of combined use of 1 alpha-hydroxyvitamin D3 with calcium supplements in the treatment of osteoporosis].
Yoshikawa S; Ohno A; Moro K; Matsumoto M; Nemoto H; Seki H; Kaneko N; Hosokawa O; Ishijima H
Nihon Seikeigeka Gakkai Zasshi; 1988 Aug; 62(8):723-32. PubMed ID: 3235892
[TBL] [Abstract][Full Text] [Related]
16. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
Jones G; Hogan DB; Yendt E; Hanley DA
CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
[TBL] [Abstract][Full Text] [Related]
17. Effects of 1alpha-hydroxyvitamin D3 on serum calcium and immunoreactive parathyroid hormone in patients with chronic renal insufficiency.
Pietrek J; Kokot F; Kuska J
Int Urol Nephrol; 1978; 10(2):153-60. PubMed ID: 700946
[TBL] [Abstract][Full Text] [Related]
18. A low dose regime of 1 alpha hydroxyvitamin D3 in the management of senile osteoporosis: a pilot study.
Cohen HN; Farrah D; Fogelman I; Goll CC; Beastall GH; McIntosh WB; Fletcher M; Boyle IT
Clin Endocrinol (Oxf); 1980 Jun; 12(6):537-42. PubMed ID: 7398099
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of postmenopausal osteoporosis with 1-alpha(OH)D3].
Petkakov M; Popović V; Milić D; Damjanović S; Manojlović D; Mićić J
Srp Arh Celok Lek; 1995; 123(7-8):171-3. PubMed ID: 17974421
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in Osteoporosis.
Davies M; Mawer EB; Adams PH
J Clin Endocrinol Metab; 1977 Aug; 45(2):199-208. PubMed ID: 195972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]